Treatment of pilonidal disease by phenol application

Objective & Hypothesis:The literature indicates various approaches regarding the properties of phenol, the target patient group, and thecomplication and recurrence rates.

📊

Key Findings & Data:The overall success and complication rates of the application is reportedas 62-95% and 0%-2%, respectively.

💡

Conclusion & Impact:Phenol treatment in pilonidal disease can be used more frequently as an alternative method with acceptable success, complication, and recurrence rates.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

The literature indicates various approaches regarding the properties of phenol, the target patient group, and thecomplication and recurrence rates. Although phenol is most frequently used to treat the fistulated form of the disease, it can also be applied for other types. The overall success and complication rates of the application is reportedas 62-95% and 0%-2%, respectively. Phenol treatment in pilonidal disease can be used more frequently as an alternative method with acceptable success, complication, and recurrence rates.

🔖

Cite This Article

EMİROĞLU, M., KARAALİ, C., ESİN, H., AKPINAR, G., AYDIN, C. (2017). Treatment of pilonidal disease by phenol application. Turkish Journal of Surgery, Cilt: 33 - Sayı: 1, 5–9. https://ajindex.com/articles/390497

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (3)

Hodges RM. Pilonidal sinüs. Boston Med Surg J 1880; 103: 485- 486. [CrossRef] Aysan E, Ilhan M, Bektas H, Kaya EA, Sam B, Buyukpinarbasili N, et al. Prevalence of sacrococcygeal pilonidal sinus as a silent disease. Surg Today 2013; 43: 1286-1289. [CrossRef] Hendren S, Hammond K, Glasgow SC, Perry WB, Buie WD, Steele SR, et al. Clinical practice guidelines for ostomy surgery. Dis Colon Rectum 2015; 58: 375-387. [CrossRef] Tezel E. Pilonidal hastalığın cerrahi tedavisi. MN Medikal-Nobel 2009: 5-17. Bascom J. Pilonidal disease: origin from follicles of hairs and results of follicle removal as treatment. Surgery 1980; 87: 567-572. Karydakis GE. New approach to the problem of pilonidal sinus. Lancet 1973; 2: 1414-1415. [CrossRef] Kanat BH, Sözen S. Disease that should be remembered: Sacrococcygeal pilonidal sinus disease and short history. World J Clin Cases 2015; 3: 876-879. [CrossRef] Nordon IM, Senapati A, Cripps NP. A prospective randomized controlled trial of simple Bascom’s technique versus Bascom’s cleft closure for the treatment of chronic pilonidal disease. Am J Surg 2009; 197: 189-192. [CrossRef] Kayaalp C, Aydin C. Review of phenol treatment in sacrococcygeal pilonidal disease. Tech Coloproctol 2009; 13: 189-193. [CrossRef] Goodall P. The aetiology and treatment of pilonidal sinus. A review of 163 patients. Br J Surg 1961; 49: 212-218. [CrossRef] Arık MK, Borazan E. Pilonidal sinüste minimal invaziv cerrahi ile kombine fenol uygulamalarımız. Anatol J Clin Investig 2011; 5: 165-168. Cengiz T. Endodonti 4. Baskı,
Barış Yayınları, İzmir, 267, 1996. 13. CA Lahoud, JA March, DD Proctor. Campho-Phenique ingestion: an intentional overdose. South Med J 1997; 6: 647-648. [CrossRef] Dag A, Colak T, Turkmenoglu O, Sozutek A, Gundogdu R. Phenol procedure for pilonidal sinus disease and risk factors for treatment failure. Surgery 2012; 151: 113-117. [CrossRef] Aksoy HM, Aksoy B, Egemen D. Effectiveness of topical use of natural polyphenols for the treatment of sacrococcygeal pilonidal sinus disease: a retrospective study including 192 patients. Eur J Dermatol 2010; 20: 476-481.
Kaymakcioglu N, Yagci G, Simsek A, Unlu A, Tekin OF, Cetiner S, et al. Treatment of pilonidal sinus by phenol application and factors affecting the recurrence. Tech Coloproctol 2005; 9: 21-24. [CrossRef] Topuz O, Sözen S, Tükenmez M, Topuz S, Vurdem UE. Crystallized phenol treatment of pilonidal disease improves quality of life. Indian J Surg 2014; 76: 81-84. [CrossRef] Akan K, Tihan D, Du